GFR Pharmaceuticals, Inc., through its subsidiaries, primarily engages in a joint operation of a positive emission tomography scanner and rotary gamma ray stereotactic neurosurgery system imaging center in the People s Republic of China. It owns and provides radiology and oncology equipment used for radiological imaging for the brain, body, and cancer treatment; and operates cancer diagnosis and treatment center. The company is also involved in the research, development, manufacture, and distribution of biological separation medium products to separate and purify biosynthetic products from natural sources, such as animal or plant tissue, or fermentation broth. GFR Pharmaceuticals, Inc. is headquartered in Xi'an, the People's Republic of China.